<DOC>
	<DOCNO>NCT00377468</DOCNO>
	<brief_summary>The purpose study determine whether application low dose Delta9-Tetrahydrocannabinol prevent development chronic pain patient acute CRPS .</brief_summary>
	<brief_title>Effect Delta-9-Tetrahydrocannabinol Prevention Chronic Pain Patients With Acute CRPS ( ETIC-Study )</brief_title>
	<detailed_description>Recent animal data suggest endocannabinoid system promise target prevention chronic pain . It show endocannabinoid system modify excitatory inhibitory current structure involve development chronic pain amygdala . CRPS neuropathic pain condition , know become chronic significant percentage . The study compare effect low dose Delta9-Tetrahydrocannabinol ( 90 day ) placebo acute CRPS . All patient receive standard treatment consist drug therapy physiotherapy .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Somatoform Disorders</mesh_term>
	<mesh_term>Complex Regional Pain Syndromes</mesh_term>
	<mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Patients clinical diagnosis acute CRPS ( time incite event le 16 week ) upper extremity No risk dependency psychological assessment History alcohol drug abuse Cardiac arrhythmia Acute chronic renal failure ASA physical status classification III high Psychiatric disorder Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>THC</keyword>
	<keyword>CRPS</keyword>
	<keyword>Pain</keyword>
	<keyword>Complex Regional Pain Syndrome</keyword>
	<keyword>Neuropathic Pain</keyword>
	<keyword>Chronic</keyword>
	<keyword>Prevention</keyword>
</DOC>